What is the difference between OOS / OOE / OOT?
Recommendation
Tuesday, 4 February 2025 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
The terms OOS, OOE and OOT always emerge in connection with the handling of deviating analysis results. But what are their definitions?
For some time, ECA's Quality Control Working Group has published a SOP on the handling of OOS results and is currently planning the elaboration of a SOP on OOE and OOT. The OOS SOP respectively the draft of the OOT SOP contains the following definitions for the three terms:
Out-of-Specification (OOS) Results
A result that falls outside established acceptance criteria which have been established in official compendia and/or by company documentation.
Out-of-Expectation (OOE) Results
An atypical, aberrant or anomalous result within a series of results obtained over a short period of time is an OOE result. An OOE result is a result that meets specifications, but is outside the expected variability of the analytical procedure.
Out of Trend (OOT) Results
A time dependent result which falls outside a prediction interval or fails a statistical process control criterion.
A trend is a sequence of temporal procedures, e.g. for the manufacture of different batches of a product. There are two types of trends:
In one case, no trend is expected, e.g. in production or when analysing process data where everyone expects that they are under statistical control.
In the other case, a trend is expected. One typical example for that is stability testing where one expects that the content of the API reduces over the storage period, or that the quantity of impurities increases over time.
There is a fundamental difference between these two types of OOT results: indeed, in the second situation the dispersion increases over time.
The new Chapter 5 of the EU GMP Guide - coming into force on 1st October 2014 - requires that in future certain data have to be recorded so that trends can be recognized and assessed.
PS: At the OOT Forum organised by ECA's QC Working Group from 22 -23 October 2014 in Prague, Czech Republic, ECA's draft SOP on OOE and OOT results will be presented.
Related GMP News
09.12.2024Another FDA Warning Letter Based on Review of Records
04.12.2024FDA Warning Letter to South African OTC Drug Manufacturer
02.12.2024How to keep Analytical Systems Current and Compliant
27.11.2024FDA Inspections in the EU: Warning Letter to Italian OTC Drug Manufacturer
21.11.2024New GMP Journal Article on Analytical Instrument Qualification and System Validation
21.11.2024FDA Warns Chinese OTC Drug Manufacturer Following Review of Records